International Symposium on Immune Diversity and Cancer Therapy Kobe 2017

作者:中国免疫学会    来源自:中国免疫学会    点击数:4461   发布时间:2016-09-08


       The aim of this symposium is to link Cancer and Immunology by discussing the achievements of cancer immunotherapy, AID-induced genomic instability and immunodeficiency prone to malignancy at the same time to open up new and broad insights into this “cancer and immunology” field. Recently emerging developments in these fields urge the necessity of discussion among researchers in both fields. This symposium is planned to provide the place for the establishment of a novel research trend focusing on both cancer and immunology. In the symposium, there will be 20 eminent guest speakers from all over the world and some poster presentations. We hope and expect many researchers and students will participate in this symposium and have a valuable opportunity to obtain new viewpoints on immune diversity and cancer therapy during the two days of the symposium.

Yoichi Nabeshima
Chair, Organizing Committee of International Symposium on Immune Diversity and Cancer Therapy Kobe 2017


       会议网址:http://www.congre.co.jp/idct2017/

回到顶部